Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8538)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2018 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pavel MC, Fuster J. Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions. World J Gastroenterol 2018; 24(32): 3626-3636 [PMID: 30166858 DOI: 10.3748/wjg.v24.i32.3626] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i32/3626.htm |
| Number | Citing Articles |
| 1 |
Joana Ferrer-Fàbrega, Jaime Sampson-Dávila, Alejandro Forner, Victor Sapena, Alba Díaz, Ramón Vilana, Miquel Navasa, Constantino Fondevila, Rosa Miquel, Carmen Ayuso, Juan Carlos García-Valdecasas, Jordi Bruix, María Reig, Josep Fuster. Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival. Journal of Hepatology 2021; 75(5): 1154 doi: 10.1016/j.jhep.2021.06.015
|
| 2 |
Renguo Guan, Wenping Lin, Jingwen Zou, Jie Mei, Yuhua Wen, Lianghe Lu, Rongping Guo. Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma. Cancer Control 2022; 29: 107327482211028 doi: 10.1177/10732748221102820
|
| 3 |
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery. Expert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
|
| 4 |
Shao-cheng Lyu, Jing Wang, Zhang-yong Ren, Di Cao, Qiang He. Prognosis of Liver Transplantation for Hepatocellular Carcinoma in Terms of Different Criteria: A Single Center Experience. Current Medical Science 2022; 42(3): 548 doi: 10.1007/s11596-022-2558-8
|
| 5 |
Da-li Zhang, Dan-ni Feng, Xi He, Xiao-feng Zhang, Li-xin Li, Zhi-jie Li, Xiao-feng Niu, Yun-long Zhuang, Zhen-wen Liu, Xu-dong Gao, Hong-bo Wang. The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.959151
|
| 6 |
A. Bogdanovic, P. Bulajic, D. Masulovic, N. Bidzic, M. Zivanovic, D. Galun. Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83868-9
|
| 7 |
Nam Hoang Duc. Liver Transplantation - Challenges and Opportunities [Working Title]. 2024; doi: 10.5772/intechopen.1004265
|
| 8 |
Douglas N. VanDerwerken, Nicholas L. Wood, Dorry L. Segev, Sommer E. Gentry. The Precise Relationship Between Model for End‐Stage Liver Disease and Survival Without a Liver Transplant. Hepatology 2021; 74(2): 950 doi: 10.1002/hep.31781
|
| 9 |
Mehmet Haluk Morgul, Philipp Felgendreff, Andreas Kienlein, Ulrich Gauger, Katrin Semmling, Hans-Michael Hau, Hans-Michael Tautenhahn, Michael Bartels. Milan criteria in the MELD era—is it justifiable to extend the limits for orthotopic liver transplantation?. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01932-6
|
| 10 |
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience. Annals of Gastroenterological Surgery 2020; 4(3): 208 doi: 10.1002/ags3.12316
|
| 11 |
S. E. Voskanyan, E. V. Naidenov, A. I. Artemiev, I. Yu. Kolyshev, D. A. Zabezhinsky, K. K. Gubarev, V. S. Rudakov, M. V. Shabalin, A. I. Sushkov, M. V. Popov, D. S. Svetlakova, A. P. Maltseva, M. Muktarzhan, Z. Sadykhov, E. V. Vidmer. Long-term results of liver transplantation for hepatocellular cancer. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2021; 26(2): 68 doi: 10.16931/10.16931/1995-5464.2021-2-68-82
|
| 12 |
Marco Biolato, Tiziano Galasso, Giuseppe Marrone, Luca Miele, Antonio Grieco. Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation. Cancers 2021; 13(24): 6337 doi: 10.3390/cancers13246337
|
| 13 |
Anne Quesnel-Barbet, Julien Soula, Mathurin Gamichon, Ismahane Ben Gayed, François Dufossez, Pierre Bazile, Eric-André Sauleau, Pierre Parrend, Arnaud Hansske. PoleSat_2018: an optimized, automated, geomatics IT tool based on a gravitational model: strategic decision support in hospital catchment area planning. SN Applied Sciences 2020; 2(5) doi: 10.1007/s42452-020-2735-y
|
| 14 |
Weiwei Liu, Lifan Zhang, Zhaodan Xin, Haili Zhang, Liting You, Ling Bai, Juan Zhou, Binwu Ying. A Promising Preoperative Prediction Model for Microvascular Invasion in Hepatocellular Carcinoma Based on XGBoost Algorithm. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3935656
|
| 15 |
Jina Kim, Yong Tae Kim, Jae Geun Lee, Dai Hoon Han, Dong Jin Joo, Do Young Kim, Jinsil Seong. Liver-Directed Combined Radiation Therapy for Downstaging Beyond-Milan Hepatocellular Carcinoma to Liver Transplantation. International Journal of Radiation Oncology*Biology*Physics 2024; doi: 10.1016/j.ijrobp.2024.01.221
|
| 16 |
Xi-Zhen Chen, Wei Kevin Zhang, He-Bin Tang, Xiao-Jun Li, Gui-Hua Tian, Hong-Cai Shang, Yu-Sang Li. The Ethanol Supernatant Extracts of Liushenwan Could Alleviate Nanodiethylnitrosamine-Induced Liver Cancer in Mice. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6934809
|
| 17 |
Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo. Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma. Clinical and Molecular Hepatology 2021; 27(4): 589 doi: 10.3350/cmh.2021.0038
|
| 18 |
Eric vanSonnenberg, Peter R. Mueller. Complex Therapeutic Strategies for Hepatocellular Carcinoma: Expanding Criteria. Radiology 2019; 293(3): 716 doi: 10.1148/radiol.2019192151
|
| 19 |
Wei Yang, Yingying Liu, Ruoling Gao, Zenghe Xiu, Ting Sun. Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistance. Cellular Signalling 2019; 60: 122 doi: 10.1016/j.cellsig.2019.04.011
|
| 20 |
Javier Tejedor-Tejada, Carmen Alonso-Martín, Carolina Almohalla-Álvarez, Esteban Fuentes Valenzuela, Rodrigo Nájera Muñoz, Laura Sánchez Delgado, Carlos Maroto Martín, Fátima Sánchez-Martín, Félix García-Pajares, Gloria Sánchez-Antolín. Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective Analysis. Transplantation Proceedings 2020; 52(5): 1507 doi: 10.1016/j.transproceed.2020.02.058
|
| 21 |
Hugo Pinto-Marques, Joana Cardoso, Sílvia Silva, João L. Neto, Maria Gonçalves-Reis, Daniela Proença, Marta Mesquita, André Manso, Sara Carapeta, Mafalda Sobral, Antonio Figueiredo, Clara Rodrigues, Adelaide Milheiro, Ana Carvalho, Rui Perdigoto, Eduardo Barroso, José B. Pereira-Leal. A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation. Annals of Surgery 2022; 276(5): 868 doi: 10.1097/SLA.0000000000005637
|
| 22 |
Elizabeth Sweeney, Tim Cross. Liver Disease in Clinical Practice. In Clinical Practice 2022; : 327 doi: 10.1007/978-3-031-10012-3_16
|
| 23 |
宁宁 胡. Effect of Preoperative Treatment on Survival of Patients with Hepatocellular Carcinoma after Liver Transplantation. Advances in Clinical Medicine 2023; 13(03): 2903 doi: 10.12677/ACM.2023.133411
|
| 24 |
Hansen Dang, Yee Hui Yeo, Satoshi Yasuda, Chung‐Feng Huang, Etsuko Iio, Charles Landis, Dae Won Jun, Masaru Enomoto, Eiichi Ogawa, Pei‐Chien Tsai, An Le, Matthew Liu, Mayumi Maeda, Brian Nguyen, Nathan Ramrakhiani, Linda Henry, Ramsey Cheung, Akihiro Tamori, Takashi Kumada, Yasuhito Tanaka, Ming‐Lung Yu, Hidenori Toyoda, Mindie H. Nguyen. Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West. Hepatology 2020; 71(6): 1910 doi: 10.1002/hep.30988
|
| 25 |
Meng-Jun Xiong, Chirag Patel, Upender Manne, Sameer Al Diffalha. Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature. Hepatic Oncology 2021; 8(1) doi: 10.2217/hep-2020-0015
|
| 26 |
Silvia Liu, Michael A. Nalesnik, Aatur Singhi, Michelle A. Wood‐Trageser, Parmjeet Randhawa, Bao‐Guo Ren, Abhinav Humar, Peng Liu, Yan‐Ping Yu, George C. Tseng, George Michalopoulos, Jian‐Hua Luo. Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients. Hepatology Communications 2022; 6(4): 710 doi: 10.1002/hep4.1846
|
| 27 |
Volkan Ince, Tevfik Tolga Sahin, Sami Akbulut, Sezai Yilmaz. Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria. World Journal of Clinical Cases 2022; 10(29): 10413-10427 doi: 10.12998/wjcc.v10.i29.10413
|
| 28 |
Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi, David M. Liu. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 2023; 115: 102526 doi: 10.1016/j.ctrv.2023.102526
|
| 29 |
Yenisetti Rajendra Prasad, J. Anakha, Abhay H. Pande. Treating liver cancer through arginine depletion. Drug Discovery Today 2024; 29(4): 103940 doi: 10.1016/j.drudis.2024.103940
|
| 30 |
Sang Jin Kim, Jong Man Kim. Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review. Clinical and Molecular Hepatology 2022; 28(4): 739 doi: 10.3350/cmh.2022.0060
|
| 31 |
Tejaswini Reddy, Abdullah Esmail, Jenny C. Chang, Rafik Mark Ghobrial, Maen Abdelrahim. Utility of Cell-Free DNA Detection in Transplant Oncology. Cancers 2022; 14(3): 743 doi: 10.3390/cancers14030743
|
| 32 |
Savio G. Barreto, Simone I. Strasser, Geoffrey W. McCaughan, Michael A. Fink, Robert Jones, John McCall, Stephen Munn, Graeme A. Macdonald, Peter Hodgkinson, Gary P. Jeffrey, Bryon Jaques, Michael Crawford, Mark E. Brooke-Smith, John W. Chen. Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0. Cancers 2022; 14(11): 2777 doi: 10.3390/cancers14112777
|
| 33 |
Maneerat Chayanupatkul, Maya Gambarin‐Gelwan, Thomas D. Schiano. The presence of non‐hepatic malignancy and its implication in pursuing liver transplantation. Clinical Transplantation 2021; 35(10) doi: 10.1111/ctr.14410
|
| 34 |
Alberto Zanetto, Sarah Shalaby, Martina Gambato, Giacomo Germani, Marco Senzolo, Debora Bizzaro, Francesco Paolo Russo, Patrizia Burra. New Indications for Liver Transplantation. Journal of Clinical Medicine 2021; 10(17): 3867 doi: 10.3390/jcm10173867
|
| 35 |
Astrid Bauschke, Annelore Altendorf-Hofmann, Lukas Brückner, Robert Drescher, Martin Freesmeyer, Utz Settmacher. Impact of metabolic indices of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(4): 1401 doi: 10.1007/s00432-022-04009-x
|